Search clinical trials for: gemigliptin and metformin HCl extended release
Total 897 results
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
AstraZenecaCompletedType 2 DiabetesUnited States, Puerto Rico, Mexico, Russian Federation, Romania, Poland, Czech Republic, United Kingdom
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)RecruitingMenopause | Irritable MoodUnited States
-
Nantes University HospitalChiesi Farmaceutici S.p.A.CompletedDiabetes | Kidney Transplantation | Pancreas TransplantationFrance
-
St. Joseph's Healthcare HamiltonBausch Health, Canada Inc.Active, not recruiting
-
Roswell Park Cancer InstituteSuspendedLung Non-Small Cell Carcinoma | Pleural DisorderUnited States
-
Hospital Central Dr. Luis OrtegaCompleted
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)SuspendedExtended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use DisorderOpioid-use DisorderUnited States
-
Sumithira VasuKiadis PharmaRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blasts 10 Percent or More of Bone Marrow Nucleated Cells | Allogeneic Stem Cell Transplant RecipientUnited States
-
Johnson & Johnson Taiwan LtdTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer... and other conditionsUnited States
-
Soleno Therapeutics, Inc.Not yet recruitingSH2B1 Deficiency Obesity | Obesity Associated With PCSK1 Mutation (rs6232 Variant) | SIM1 Deficiency Obesity
-
NYU Langone HealthNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Dependence | Alcohol Use DisorderUnited States
-
Luye Pharma Group Ltd.Completed
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA); Alkermes, Inc.CompletedAlcohol Dependence | Cocaine DependenceUnited States
-
NovartisCompletedDyslipidemiaGermany, Switzerland
-
Rhodes Pharmaceuticals, L.P.UnknownAttention Deficit Disorder With HyperactivityUnited States
-
Henry Ford Health SystemCompletedIschemic StrokeUnited States
-
McNeil Consumer & Specialty Pharmaceuticals, a...CompletedAttention Deficit Disorder With Hyperactivity
-
McNeil Consumer & Specialty Pharmaceuticals, a...CompletedAttention Deficit Hyperactivity Disorder
-
AbbottCompleted
-
Duke UniversityAlkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources... and other collaboratorsCompletedOpioid-Related DisordersUnited States
-
Merck Sharp & Dohme LLCTerminatedHypercholesterolemia, Familial | Heterozygous Familial Hypercholesterolemia
-
University at BuffaloAstraZenecaTerminatedKidney Diseases | Type2 DiabetesUnited States
-
Yungjin Pharm. Co., Ltd.Chonbuk National University HospitalCompleted
-
Theresa Zesiewicz, MDTerminatedRestless Leg SyndromeUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedFatigue | Anemia | Weight Loss | Thrombocytopenia | Fever | Refractory Plasma Cell Myeloma | Lymphadenopathy | Refractory Chronic Lymphocytic Leukemia | Recurrent Plasma Cell Myeloma | Splenomegaly | Recurrent Chronic Lymphocytic Leukemia | Lymphocytosis | Night SweatsUnited States
-
UConn HealthYale University; ShireWithdrawn
-
Massachusetts General HospitalCompletedAlzheimer DementiaUnited States
-
Boston UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Dependence | Alcohol Use Disorder | Heavy DrinkingUnited States
-
ShireCompletedPhobia, Social | Anxiety, Separation | Generalized Anxiety Disorder (GAD)United States
-
NYU Langone HealthCompletedAlcohol DependenceUnited States
-
New York State Psychiatric InstituteShireCompletedOppositional Defiant Disorder | Attention Deficit Disorder | Childhood Aggression | Intermittent Explosive DisorderUnited States
-
Tocagen Inc.CompletedGlioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic OligodendrogliomaUnited States
-
Forest LaboratoriesMerz Pharmaceuticals GmbHCompleted
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaboratorsCompletedOpioid-Related Disorders | Heroin DependenceUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH); Massachusetts General Hospital; University... and other collaboratorsCompletedPervasive Development DisordersUnited States
-
Peter A KnightCompletedCoronary Artery Disease | Pain, PostoperativeUnited States
-
University of LeipzigCompletedCoronary Disease | HypolipoproteinemiaGermany
-
Centre de Recherche en Nutrition Humaine Rhone-AlpeGlaxoSmithKline; Institut National de la Santé Et de la Recherche Médicale,...CompletedInsulin Sensitivity | Lipid Profile | Lipoproteins Metabolism | Non Esterified Fatty Acid KineticsFrance
-
Seattle Institute for Biomedical and Clinical ResearchAbbottCompletedAlcoholism | Mood Disorders | Alcohol Related DisordersUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Boehringer IngelheimCompleted
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Colombia, Mexico, Portugal, Bulgaria, India, Malaysia, Turkey, Ukraine, Greece, Sweden, Singapore, Czech Republic, Argentina, Puerto Rico, Russian Federation, Thailand, Slovakia, Latvia, Estonia, Peru